Results 241 to 250 of about 320,119 (385)

Genomic analysis of teicoplanin resistance emerging during treatment of vanB vancomycin-resistant Enterococcus faecium infections in solid organ transplant recipients including donor-derived cases [PDF]

, 2013
Natasha E. Holmes, Susan A. Ballard, Margaret M. C. Lam, Paul D. R. Johnson, M. Lindsay Grayson, Timothy P. Stinear, Benjamin P. Howden   +6 more
openalex   +1 more source

RADIOSTABILITY OF VANCOMYCIN [PDF]

, 2006
Baert, Bram, Bodé, Samuel, De Brabander, Hubert, De Spiegeleer, Bart, Remon, Jean Paul, Thierens, Hubert, VAN HOOF, N, Van Hoorebeke, Luc, Vangheluwe, Elien   +8 more
core   +1 more source

Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous Vancomycin

Antimicrobial Agents and Chemotherapy, 2017
E. Zasowski, K. P. Murray, T. Trinh, Natalie A. Finch, J. Pogue, Ryan P. Mynatt, M. Rybak   +6 more
semanticscholar   +1 more source

Host Transcriptomics and Culture‐Independent Testing for the Management of Febrile Neutropenia: Data From an Observational Study Conducted in a Bone Marrow Transplant Unit

European Journal of Haematology, EarlyView.
ABSTRACT Background Managing febrile neutropenia is challenging due to the limited sensitivity of blood culture (BC) and the lack of tools differentiating infectious from non‐infectious fever. T2 magnetic resonance (T2MR) is a culture‐independent system detecting bacteria (T2Bacteria) and yeasts (T2Candida); SeptiCyte RAPID is a host response assay ...
Anna Maria Peri, Andrea S. Henden, Ricky Nelles, Mark D. Chatfield, Patrick N. A. Harris, Glen Kennedy, David L. Paterson   +6 more
wiley   +1 more source

[Translated article] Complications of intraosseous administration of vancomycin in total hip arthroplasty

Walter Martínez, L. Camacho Terceros, Francesca Garbini, E Bochatey, Fernando Lopreite   +4 more
openalex   +1 more source

Increased Glycan Chain Length Distribution and Decreased Susceptibility to Moenomycin in a Vancomycin-Resistant Staphylococcus aureus Mutant [PDF]

, 2002
Hitoshi Komatsuzawa, Kouji Ohta, Sakuo Yamada, Kerstin Ehlert, Harald Labischinski, Junko Kajimura, Tamaki Fujiwara, Motoyuki Sugai   +7 more
openalex   +1 more source

Meropenem‐Heparin Lock Therapy for Ochrobactrum intermedium Catheter‐Related Bloodstream Infection in a Pediatric Hemodialysis Patient: A Case Report and Literature Review

Hemodialysis International, EarlyView.
ABSTRACT Background In pediatric hemodialysis patients with exhausted vascular access, managing rare pathogens like Ochrobactrum intermedium is challenging, often posing a dilemma between catheter removal and salvage attempts. There are few reports on the supported viability of meropenem‐heparin lock therapy for this purpose in pediatric patients. Case
Mônica Cristina Dutra Rodrigues, Fernanda Teixeira Sillva, Anderson Pereira de Oliveira, Yeo Jim Kinoshita Moon, Jhohann Richard de Lima Benzi   +4 more
wiley   +1 more source

Investigating the relationship between vancomycin-resistant Enterococcus control practices and the incidence of health care–associated Clostridioides difficile infections in Ontario [PDF]

, 2019
Rebecca Ling, Camille Achonu, Li Ye, Kevin Katz, Gary Garber, Jennie Johnstone   +5 more
openalex   +1 more source

Vancomycin Prophylaxis for Total Joint Arthroplasty: Incorrectly Dosed and Has a Higher Rate of Periprosthetic Infection Than Cefazolin

Clinical Orthopaedics and Related Research, 2017
M. Kheir, T. Tan, I. Azboy, D. Tan, J. Parvizi   +4 more
semanticscholar   +1 more source

Classification of Platelet‐Activating Anti‐Platelet Factor 4 Disorders

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction The prototypic anti‐platelet factor 4 (PF4) disorder—heparin‐induced thrombocytopenia and thrombosis (HITT)—features immunoglobulin G (IgG) class antibodies that activate platelets, monocytes, and neutrophils in a mainly heparin‐dependent fashion via Fcγ receptor‐dependent cellular activation.
Theodore E. Warkentin
wiley   +1 more source